University of California San Francisco

Give to UCSF
Advanced
3130 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics
Displaying 2641 - 2670 of 3130
  • UCSF Medical Center receives $125 million gift to build new hospital

    UCSF Medical Center has received a $125 million gift for its campaign to build a children’s, women’s specialty and cancer hospital complex at the UCSF Mission Bay campus, near downtown San Francisco. This is the largest support to date for the $600 million hospital fundraising campaign and among the largest gifts in UCSF’s history.

    Placeholder image
  • Team recommends greater cultural awareness in end-of-life care for Latino patients

    A team of physicians at the San Francisco VA Medical Center and University of California, San Francisco recommends more effective use of interpreters, greater awareness of potential areas of mistrust and misunderstanding, better communication with families, and better knowledge of cultural differences in general when planning end-of-life and palliative care for Latino patients in the United States.

    Placeholder image
  • Barriers to adoption of electronic personal health records outlined

    Interest in personal health records as an electronic tool to manage health information is increasing dramatically. A group led by a UCSF researcher has identified cost, privacy concerns, design shortcomings and difficulties sharing information across different organizations as critical barriers hindering broad implementation of electronic personal health records.

    Placeholder image
  • Metabolic syndrome linked to women's cognitive impairment risk

    Older women with the metabolic syndrome – a constellation of health-risk factors – had a 66 percent increase in risk of developing cognitive impairment compared with women who did not have the syndrome, according to a large study of post-menopausal women led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.

    Placeholder image
  • High blood pressure linked to earlier death among African-American breast cancer patients

    A study by researchers at the University of California, San Francisco has shown that hypertension, or high blood pressure, is a predictor of mortality among breast cancer patients, especially those who are African-American, and that hypertension accounts for approximately 30 percent of the survival disparity between African-American and white breast cancer patients.

    Placeholder image
  • Study sheds light on angiogenesis inhibitors, points to limitations, solutions

    A new generation of cancer drugs designed to starve tumors of their blood supply – called “angiogenesis inhibitors” -- succeeds at first, but then promotes more invasive cancer growth -- sometimes with a higher incidence of metastases, according to a new study in animals. The research clarifies similar findings in other animal studies and is consistent with some early evidence from a small number of clinical trials with cancer patients.

    Placeholder image
  • Effective mentoring critical to HIV/AIDS research efforts

    An innovative mentoring program at the UCSF-Gladstone Institute for Virology and Immunology Center for AIDS Research is providing vital support for the development of the next generation of HIV/AIDS researchers and clinician scientists.

    Placeholder image
  • Statins pay off on a health-policy level, UCSF study finds

    Current guidelines for when to prescribe popular cholesterol-lowering drugs called statins would produce cost-effective results and would save thousands of lives every year if they were followed more closely by physicians and patients, according to a new study led by researchers at the University of California, San Francisco.

    Placeholder image
  • UCSF symposium considers biomedical approaches to HIV/AIDS prevention

    New and emerging biomedical approaches to HIV/AIDS prevention will be the focus of a daylong symposium on February 24 sponsored by the UCSF-Gladstone Institute for Virology and Immunology Center for AIDS Research (CFAR) and the UCSF Center for AIDS Prevention Studies.

    Placeholder image
  • Drug discovery short-circuits cancer growth

    A new drug that blocks cancer's main source of growth has been created in the lab and proven effective in mice, scientists are reporting. It is now being readied for clinical trials in patients.

    Placeholder image
  • Study explores underuse of interpreters in hospitals

    A new study has found that resident physicians at teaching hospitals underuse interpreter services — often relying on hand gestures or a limited number of words in the patient’s native language.

    Placeholder image
  • Perceptions and experiences of homeless youth vary by race, UCSF study shows

    The self-perceptions and life experiences of young homeless people vary significantly by race, according to a new study by researchers at the University of California, San Francisco. The findings underscore the need for a more tailored approach to youth homelessness intervention and prevention programs.

    Placeholder image
  • Children with inflammatory bowel disease have surprisingly high folate levels, study finds

    Children with newly diagnosed cases of inflammatory bowel disease have higher concentrations of folate in their blood than individuals without IBD, according to a new study led by researchers at the University of California, San Francisco and UC Berkeley. The findings bring into question the previously held theory that patients with IBD are prone to folate – also known as folic acid – deficiency.

    Placeholder image
  • Iraqi boy undergoes surgery to restore hearing

    A 3-year-old Iraqi boy will undergo surgery at UCSF Medical Center today (Friday, January 16), to restore his hearing, which was destroyed in June 2007 when a U.S. explosive device hit his neighbor’s house.

    Placeholder image
  • UCSF VA researchers call drug company deceptions typical

    The pharmaceutical company Parke-Davis employed “the systematic use of deception and misinformation” in order to manipulate physicians into prescribing the drug gabapentin for so-called off-label uses, write two San Francisco VA Medical Center physicians in the New England Journal of Medicine.

    Placeholder image